Conference Series LLC invites all the participants from all over the world to attend “International Conference on Cancer Biomarkers “to be held on August 07-09, 2017, at Osaka, Japan with the main theme “Innovation and Implementation: Cancer Treatment”
The global Biomarkers Congress market for 2007 was $3.6 billion and is expected to grow at a 6.3% CAGR (Compounded Annual Growth Rate) to reach up to $6.3 billion by 2017. A number of factors such as the rising demand for personalized medicine and companion diagnostics which in turn has raised the value of biomarkers in the healthcare sector. The global biomarkers Congress market is expected to grow at a 18.5% CAGR from 2013 to 2018, to reach $40.8 billion by 2018. The Biomarkers Congress is very much encouraged to spread the knowledge of advances in these days.
Biomarkers Congress 2017, in the hands of clinical investigators, provide a dynamic and powerful approach to understanding the spectrum of diseases with obvious applications in analytic epidemiology, biomarkers and clinical research in disease prevention, diagnosis, and disease management. Cancer biomarkers have the additional potential to identify individuals susceptible to disease. There is a good scope to know more in this Biomarker Congress In the recent years, the information about cancer biomarkers has increased largely providing great scope for improving the management of cancer patients by improving the accuracy of detection and efficacy of treatment. Latest technological advancement has enabled the examination of many possible biomarkers and renewed interest in developing new biomarkers. All such developments can be evidenced in this Cancer biomarker conference.
A comprehensive discussion of the significance of each biomarker like pharmacodynamics and toxic dynamics of protein biomarkers, analytical biomarkers, and epigenetic biomarkers is going to be held in this biomarkers congress. This conference also includes symposiums and workshop events.
Sessions and Tracks
Biomarker Congress 2017 is a platform to discuss and learn about the latest advancements in the field of Molecular and Cancer Biomarkers and their journey from labs to industry scale production. Biomarkers have been a great tool in the new generation diagnosis, prognosis and treatment of various diseases. Molecular biomarkers include proteins, lipids, DNA, RNA and several other components in the body. Their applications in some disease pathologies have gained a prominence over period like in cancer and Alzheimer’s diseases.
- Molecular Biomarkers Discovery
- Translational Biomarkers
- Biomarkers: Validation and Verification
- Clinical Biomarkers
- Biomarkers : Cancers
- Biomarkers and Diseases
- Cell Free Biomarkers
- Predictive Cancer Biomarkers
- Advances of Biomarker Testing
- Biomarker and Personalized Medicine
- Companion Diagnostics
- Biomarkers & Pharmacology
- Molecular Imaging and Dynamics
- Case Reports
- Biomarkers Entrepreneurs Investment Meet
Conference Series LLC, the host of this conference is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe